相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic variants in levodopa-induced dyskinesia (LID): A systematic review and meta-analysis
Marika Falla et al.
PARKINSONISM & RELATED DISORDERS (2021)
Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression
Zulvikar Syambani Ulhaq et al.
HELIYON (2021)
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
Ana Rakita et al.
SCIENTIFIC REPORTS (2020)
Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease
Malgorzata Michalowska et al.
BRAIN AND BEHAVIOR (2020)
Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia
Zulvikar Syambani Ulhaq et al.
MEDICINA CLINICA (2020)
Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis
Gita Vita Soraya et al.
MEDICINA CLINICA (2020)
The role of IL-6-174 G/C polymorphism and intraocular IL-6 levels in the pathogenesis of ocular diseases: a systematic review and meta-analysis
Zulvikar Syambani Ulhaq et al.
SCIENTIFIC REPORTS (2020)
Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease
Erinaldo Ubirajara Damasceno dos Santos et al.
NEUROMOLECULAR MEDICINE (2019)
Pharmacogenetics and levodopa induced motor complications
Kallirhoe Kalinderi et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
The influence of SLC6A3 and DRD2 polymorphisms on levodopa-therapy in patients with sporadic Parkinson's disease
Erinaldo Ubirajara Damasceno dos Santos et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
DAT gene polymorphisms (rs28363170, rs393795) and levodopa-induced dyskinesias in Parkinson's disease
Carlo Purcaro et al.
NEUROSCIENCE LETTERS (2019)
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease
Tiago Furtado Sampaio et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey
S. Perez-Lloret et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease
Cristoforo Comi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson's disease
Yiwei Qian et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson's Disease
Natalie Kaplan et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Influence of Single Nucleotide Polymorphisms in COMT, MAO-A and BDNF Genes on Dyskinesias and Levodopa Use in Parkinson's Disease
Perdita Cheshire et al.
NEURODEGENERATIVE DISEASES (2014)
Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population
Hongying Hao et al.
PARKINSONISM & RELATED DISORDERS (2014)
Catechol-O-methyltransferase Val158Met polymorphism: Modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease
Hui Wu et al.
PARKINSONISM & RELATED DISORDERS (2014)
The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations
Lu Lechun et al.
NEUROLOGY INDIA (2013)
Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease
David Lindenbach et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Pharmacological treatment and the prospect of pharmacogenetics in Parkinson's disease
K. Kalinderi et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Pharmacokinetics and pharmacodynamics of levodopa
John G. Nutt
MOVEMENT DISORDERS (2008)
A method for meta-analysis of molecular association studies
A Thakkinstian et al.
STATISTICS IN MEDICINE (2005)
Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease -: An exploratory study
M Zappia et al.
ARCHIVES OF NEUROLOGY (2005)
Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease
S Papapetropoulos et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease
M Watanabe et al.
NEUROPSYCHOBIOLOGY (2003)
Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back
H Bergman et al.
MOVEMENT DISORDERS (2002)
Dopamine D5 receptor gene polymorphism and the risk of levodopa-induced motor fluctuations in patients with Parkinson's disease
J Wang et al.
NEUROSCIENCE LETTERS (2001)
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
JE Ahlskog et al.
MOVEMENT DISORDERS (2001)
Dyskinesias and motor fluctuations in Parkinson's disease - A community-based study
A Schrag et al.
BRAIN (2000)
分享论文
